| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-11 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |